61-75 of 238
Tracking Immune Activity in Severe Alopecia Areata
DermConsultTracking Immune Activity in Severe Alopecia Areata
When Alopecia Areata Signals More than Hair Loss
DermConsultWhen Alopecia Areata Signals More than Hair Loss
How COVID-19 mRNA Vaccination Restores Sensitivity to Immune Checkpoint Inhibitors
Clinician's RoundtableHow COVID-19 mRNA Vaccination Restores Sensitivity to Immune Checkpoint Inhibitors
LUMINESCE: Assessing Satralizumab in Generalized Myasthenia Gravis
NeuroFrontiersLUMINESCE: Assessing Satralizumab in Generalized Myasthenia Gravis
First-in-Human Trial of a Germline-Targeting HIV Env Trimer Vaccine
Clinician's RoundtableFirst-in-Human Trial of a Germline-Targeting HIV Env Trimer Vaccine
From Pertussis to Polio: Why Routine Childhood Vaccination Matters More Than Ever
VacciNationFrom Pertussis to Polio: Why Routine Childhood Vaccination Matters More Than Ever
Paul Offit, MD
- advertisement
Preventing Serious Infections in Immunocompromised Patients
Living RheumPreventing Serious Infections in Immunocompromised Patients
Leonard H. Calabrese, DO
Recognizing Neonatal FPIES: Key Clues for Early Diagnosis and Treatment
Clinician's RoundtableRecognizing Neonatal FPIES: Key Clues for Early Diagnosis and Treatment
Ryan Quigley
Strengthening Pediatric Immunization Against DTaP, Hepatitis B, and Polio
VacciNationStrengthening Pediatric Immunization Against DTaP, Hepatitis B, and Polio
Ruth Carrico, PhD, DNP, APRN*
Targeting CD19 in Autoimmune Neuropathy: Case Report Insights
Living RheumTargeting CD19 in Autoimmune Neuropathy: Case Report Insights
Reimagining Autoimmune Care with CAR-Based Cell Therapies
Living RheumReimagining Autoimmune Care with CAR-Based Cell Therapies
Reframing Sjögren’s Syndrome: Insights from a Comprehensive Review
Living RheumReframing Sjögren’s Syndrome: Insights from a Comprehensive Review
- advertisement
Topical Cell-Free Therapy for Psoriasis: A Sponge-Based Secretome Formulation
Clinician's RoundtableTopical Cell-Free Therapy for Psoriasis: A Sponge-Based Secretome Formulation
Efgartigimod Shows Early Promise for Primary Sjögren’s Disease
Living RheumEfgartigimod Shows Early Promise for Primary Sjögren’s Disease
Unmasking Patient Subtypes in Sjögren’s Disease to Enable Personalized Care
Living RheumUnmasking Patient Subtypes in Sjögren’s Disease to Enable Personalized Care
